Opinion

Reshaping Biotechnology's Financing Relay Race

June 13, 2009

The current economic downturn may fuel the creation of new, more sustainable business models

Comparative Effectiveness: Tools, Not Rules

June 13, 2009

Drug Wholesalers and the Generic Price War

June 01, 2009

Newly Formed Standards Charter Organization (SCO) Lays Foundation for National HIT Agenda

May 03, 2009

The stakes are high in the debate over follow-on biologics

May 03, 2009

Could proposed legislation undercut the promise of targeted therapies?

In Defense of Sales Reps

May 03, 2009

Claims of the death of the pharma sales rep occupation have been greatly exaggerated

Here We Go Again on 'Re-Importation'

March 28, 2009

Bipartisan group of senators sponsor a revived drug-importation bill

Pharma 2020: Marketing the Future

March 26, 2009

A New Business Model for Pharma Innovation

March 26, 2009

The studio model: how film industry practices can boost pharmaceutical creativity

No surprise here: FDA drug oversight is now a 'high risk' government operation

February 19, 2009

FDA’s management of drug and device safety enters GAO’s biennial watch list